Celldex Therapeutics Stock Technical Analysis
| CLDX Stock | USD 23.76 1.18 5.23% |
As of the 10th of February, Celldex Therapeutics shows the Risk Adjusted Performance of 0.0046, standard deviation of 3.21, and Mean Deviation of 2.47. Celldex Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Celldex Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Celldex, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CelldexCelldex Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Celldex Therapeutics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 53.36 | Strong Buy | 14 | Odds |
Most Celldex analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Celldex stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Celldex Therapeutics, talking to its executives and customers, or listening to Celldex conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celldex Therapeutics. Projected growth potential of Celldex fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Celldex Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.52) | Revenue Per Share | Quarterly Revenue Growth (0.71) | Return On Assets | Return On Equity |
Understanding Celldex Therapeutics requires distinguishing between market price and book value, where the latter reflects Celldex's accounting equity. The concept of intrinsic value - what Celldex Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Celldex Therapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Celldex Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Celldex Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Celldex Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Celldex Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Celldex Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Celldex Therapeutics.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Celldex Therapeutics on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Celldex Therapeutics or generate 0.0% return on investment in Celldex Therapeutics over 90 days. Celldex Therapeutics is related to or competes with Vera Therapeutics, Abcellera Biologics, Janux Therapeutics, Immunome, Biohaven Pharmaceutical, Spyre Therapeutics, and Uniqure NV. Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific ant... More
Celldex Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Celldex Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Celldex Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 14.68 | |||
| Value At Risk | (5.57) | |||
| Potential Upside | 6.44 |
Celldex Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celldex Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Celldex Therapeutics' standard deviation. In reality, there are many statistical measures that can use Celldex Therapeutics historical prices to predict the future Celldex Therapeutics' volatility.| Risk Adjusted Performance | 0.0046 | |||
| Jensen Alpha | 0.019 | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | 0.0468 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Celldex Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Celldex Therapeutics February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0046 | |||
| Market Risk Adjusted Performance | 0.0568 | |||
| Mean Deviation | 2.47 | |||
| Coefficient Of Variation | (27,862) | |||
| Standard Deviation | 3.21 | |||
| Variance | 10.27 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | 0.019 | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | 0.0468 | |||
| Maximum Drawdown | 14.68 | |||
| Value At Risk | (5.57) | |||
| Potential Upside | 6.44 | |||
| Skewness | 0.3111 | |||
| Kurtosis | 0.1931 |
Celldex Therapeutics Backtested Returns
At this stage we consider Celldex Stock to be very steady. Celldex Therapeutics secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Celldex Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Celldex Therapeutics' Mean Deviation of 2.47, standard deviation of 3.21, and Risk Adjusted Performance of 0.0046 to double-check if the risk estimate we provide is consistent with the expected return of 0.0151%. The firm shows a Beta (market volatility) of -0.46, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Celldex Therapeutics are expected to decrease at a much lower rate. During the bear market, Celldex Therapeutics is likely to outperform the market. Celldex Therapeutics right now shows a risk of 3.16%. Please confirm Celldex Therapeutics value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Celldex Therapeutics will be following its price patterns.
Auto-correlation | -0.04 |
Very weak reverse predictability
Celldex Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Celldex Therapeutics time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Celldex Therapeutics price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Celldex Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 1.44 |
Celldex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Celldex Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Celldex Therapeutics across different markets.
About Celldex Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Celldex Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Celldex Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Celldex Therapeutics price pattern first instead of the macroeconomic environment surrounding Celldex Therapeutics. By analyzing Celldex Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Celldex Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Celldex Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 240.12 | 36.4 | 32.76 | 45.62 | PTB Ratio | 4.48 | 2.18 | 2.51 | 2.38 |
Celldex Therapeutics February 10, 2026 Technical Indicators
Most technical analysis of Celldex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Celldex from various momentum indicators to cycle indicators. When you analyze Celldex charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0046 | |||
| Market Risk Adjusted Performance | 0.0568 | |||
| Mean Deviation | 2.47 | |||
| Coefficient Of Variation | (27,862) | |||
| Standard Deviation | 3.21 | |||
| Variance | 10.27 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | 0.019 | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | 0.0468 | |||
| Maximum Drawdown | 14.68 | |||
| Value At Risk | (5.57) | |||
| Potential Upside | 6.44 | |||
| Skewness | 0.3111 | |||
| Kurtosis | 0.1931 |
Celldex Therapeutics February 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Celldex stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.07 | ||
| Daily Balance Of Power | 0.72 | ||
| Rate Of Daily Change | 1.05 | ||
| Day Median Price | 23.16 | ||
| Day Typical Price | 23.36 | ||
| Price Action Indicator | 1.20 | ||
| Market Facilitation Index | 1.65 |
Additional Tools for Celldex Stock Analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.